Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection

Digestive Diseases and Sciences

Volumn 41, Issue 11, 1996, Pages 2213-2218

  Ghany, M G ^b   Chan, T M ^b   Sanchez Pescador, R ^b   Urdea, M ^b   Lok, A S F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Chronic hepatitis C; Immunosuppressive therapy; Interferon; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER INJURY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0029826316     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02071402     Document Type: Article

References (33)

1. Naito M, Hayashi N, Hagiwara H, Katayama K, Kasahara A, Fusamoto H, Kato M, Masuzawa M, Kamada T: Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C. J Hepatol 20:755-759, 1994
2. Hagiwara H, Hayashi N, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T: Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 17:545-550, 1993
3. Kato N, Yokosura O, Hosoda K, Ito Y, Ohio Omata M: Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 18:16-20, 1993
4. Gordon SC, Vallisitaram P, Kodali P, Silverman AL, Dmuchowski CF, Urdea M, Chan CS, Wilber JC: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 89:1458-1461, 1994
5. Yuki N, Hayashi N, Takehara T, Hagiwara H, Hiramatsu N, Naito M, Kawanishi Y, Katayama K, Kasahara A, Fusamoto H, Kamada T: Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol 89:1462-1466, 1994
6. Gretch D, Corey L, Wilson J, dela Rosa C, Wilson R, Carithers R Jr, Busch M, Hart J, Sayers M, Han J: Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High titer viremia correlates with advanced stage of disease. J Infect Dis 169:1219-1225, 1994
7. Shindo M, Arai K, Sokawa Y, Okuno T: The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 22:418-425, 1995
8. Lau JYN, Davis GL, Kniffen J, Qian K, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC: Significance of serum hepatitis C virus RNA in chronic hepatitis C. Lancet 341:1501-1504, 1993
9. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T: Quantitation analysis of hepatitis C virus RNA in serum during Interferon alfa therapy. Gastroenterology 104:877-883, 1993
10. Shindo M, Arai K, Sokawa Y, Okuno T: Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon alfa therapy. Ann Intern Med 122:586-591, 1995
11. Brillanti S, Garson JA, Tuke PW: Effect of alpha-interferon therapy on hepatitis C viremia in community acquired-chronic non-A, non-B hepatitis: A quantitative polymerase chain reaction study. J Med Virol 34:136-141, 1991
12. Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J: Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon treated patients. Hepatology 19:1337-1341, 1994
13. Hino K, Okuda M, Konishi T, Ishiko H, Okita K: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon alfa therapy. Dig Dis Sci 40:14-20, 1995
14. Liang TJ, Rustgi V, Galun E, Blum HE: HCV RNA in patients with chronic hepatitis C treated with interferon-alpha. J Med Virol 40:69-75, 1993
15. Magrin S, Craxi A, Fabiano C, Simoentti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdca MS, Neuwald P, Sacchez-Pescador R, Detmer J, Wilber JC, Paliaro L: Hepatitis C viremia in chronic liver disease: Relationship to interferon-alfa or corticosteroid treatment. Hepatology 19:273-279, 1994
16. Fong TL, Valinluck B, Govindarajan S, Charboneaau F, Adkins RH, Redeker AG: Short-term prednisone therapy affects hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 107:196-199, 1994
17. Lau JYN, Davis GL, Brunson ME, Quian KP, Lin HJ, Quan S, DiNello R, Polito AJ, Scornik JC: Hepatitis C virus infection in kidney transplant recipients. Hepatology 18:1027-1031, 1993
18. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M, Quan S, Sanchez-Pescador R, Wright TL: Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 106:994-996, 1994
19. Lefkowitch JH, Apfelbaum TF: Non-A, non-B hepatitis: Characterization of liver biopsy pathology. J Clin Gastroenterol 2:225-232, 1989
20. Mosnier JF, Degott C, Marcellin P, Henin D, Erlinger S, Benhamou JP: The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study. Hepatology 17:366-371, 1993
21. Poralla T, Hutteroth TH, Meyer Zum Buschenfelde KH: Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis. Gut 25:114-120, 1984
22. Mondelli M, Alberti A, Tremolada F, Williams R, Eddleston ALWF, Realdi G: In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis. Clin Exp Immunol 63:147-155, 1986
23. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD: Hepatitis C virus (HCV)-spucific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522-7532, 1993
24. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339-3344, 1992
25. Kita H, Moriyama T, Kaneko T, Harase I, Nomuta M, Miura H, Nakamura I, Yazaki Y, Imawari M: HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nuclecapsid protein. Hepatology 18:1039-1044, 1993
26. Erickson AL, Houghton M, Choo QL, Weiner AJ, Ralston R, Muchmore E, Walker CM: Hepatitis C virus CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 151:4189-4199, 1993
27. Imawari M, Nomura M, Kaieda T, Moriyama T, Oshimi K, Nakamura I, Gunji T, Ohnishi S, Ishikawa T, Nakagama H, Takaku F: Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus. Proc Natl Acad Sci USA 86:2883-2887, 1989
28. Cheung RC, Chan RT, Lok ASF: Longitudinal study of hepatitis C viremia in chronic hepatitis C. J Med Virol 41:338-342, 1993
29. Lok ASF, Cheung RC, Liu V: Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology 15:1007-1012, 1992
30. Widell A, Shev S, Mansson S, Zhang YY, Foberg U, Norkrans G, Weiland O, Kukus J, Nordenfeldt E: Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiologic applications. J Med Virol 44:272-279, 1994
31. Zhang YY, Lok ASF, Chan DTM, Widell A. A greater diversity of HCV genotypes found in Hong Kong than in mainland China. J Clin Micro (in press)
32. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH: A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325:98-104, 1991
33. Garson JA, Turk PW, Makris M, Briggs M, Machin SJ, Preston FE, Tedder RS: Demonstration of viremia patterns in hemophiliacs treated with hepatitis C virus-contaminated factor VIII concentrates. Lancet 336:1022-1025, 1990